What is the da Vinci 5 system?

It is Intuitive Surgical's latest robotic surgery system, which is seeing rapid adoption in hospitals.

How did the index changes affect the stock?

The stock was added to the Russell 1000 Dynamic Index and removed from the Russell Top 50 Index, altering its index exposure.

Intuitive Surgical Posts Strong Q2 2026 Results as Da Vinci 5 Gains Traction

Q: Why did Intuitive Surgical issue cautious guidance?

Due to competitive pressures and increased regulatory scrutiny.

Intuitive Surgical reported strong quarterly results, supported by solid procedure volumes and rapid adoption of its new da Vinci 5 system. Management issued softer guidance for future procedure growth, citing competitive pressures and increased regulatory scrutiny.

July 4, 2026

2 min read

Source: Simply Wall St.

Key Numbers

revenue

Not disclosed

procedure growth

solid

da vinci 5 adoption

rapid

Intuitive Surgical (NasdaqGS: ISRG) reported strong financial results for the second quarter of 2026, driven by higher procedure volumes and rapid adoption of its new da Vinci 5 robotic system. The company did not disclose specific revenue or net income figures but indicated robust procedure growth.

Key Financial Results

Metric	Value
Revenue	Not disclosed
Net Income	Not disclosed
Procedure Growth	Strong

Highlights from the Report

Strong adoption of the new da Vinci 5 system.
Increased surgical procedure volumes.
The stock was recently added to the Russell 1000 Dynamic Index and removed from the Russell Top 50 Index.

Future Guidance

Management issued softer guidance for future procedure growth, citing competitive pressures and increased regulatory scrutiny.

Impact on Stock

No specific stock reaction was mentioned, but the strong results support the stock in the near term.

What This Means for Investors

The results demonstrate strong demand for robotic surgery, but cautious guidance warrants monitoring competition and regulatory developments.

Frequently Asked Questions

The company reported strong results driven by procedure growth and rapid adoption of the da Vinci 5 system, but did not disclose specific revenue or net income figures.

Found this useful? Share it

This article was rewritten in Wrqti's editorial style based on information from the original source above. Content is informational only — not investment advice.